Live Breaking News & Updates on Pathogen Genomic Laboratory

Stay updated with breaking news from Pathogen genomic laboratory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Monkeypox treatment trial begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. The National Institute of Allergy andA clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. The National Institute of Allergy and » The FINANCIAL Featured ....

United States , New York , Democratic Republic Of The Congo , Jean Jacques Muyembe Tamfum , Placide Mbala , Anthonys Fauci , Us Centers For Disease , Us Department Of Health , Human Services , National Institute Of Allergy , World Health Organization , Drug Administration , Us National Institutes Of Health , Epidemiology Department , Institute Of Tropical Medicine Antwerp , Pathogen Genomic Laboratory , Alliance For International Medical Action , Technologies Inc , Kinshasa University Medical School In Gombe , National Institute For Biomedical Research , Democratic Republic , National Institute , Infectious Diseases , Biomedical Research , Disease Control , Tropical Medicine Antwerp ,